• Japanese
  • Korean
  • Chinese
Cover Image

Europe Markets for Orthopedic Biomaterials 2011-2021

Notes

This report analyzes and evaluates the current state of the European Market for Orthopedic Biomaterials, including existing and potential markets as well as product average selling prices. Please request a Free Sample to learn more.

The European market for orthopedic materials is segmented into bone graft substitutes (BGS), which includes allograft, synthetic and demineralized bone matrices (DBM); bone morphogenetic protein (BMP) growth factors; hyaluronic acid (HA) viscosupplementation; and autologous chondrocyte implantation (ACI).

The European orthopedic biomaterials market includes bone graft substitutes (BGS), hyaluronic acid (HA) viscosupplementation injections, bone morphogenetic protein (BMP) growth factor therapy and autologous chondrocyte implantations (ACI). The HA market experienced significant contractions in 2012 and 2013 due to the extreme price competition resulting from an increase in competition, especially in Germany.

Table of Contents

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

  • 1.1 EUROPEAN MARKETS FOR ORTHOPEDIC BIOMATERIALS
  • 1.2 BONE GRAFT SUBSTITUTE MARKET
  • 1.3 ALLOGRAFT BONE GRAFT SUBSTITUTE MARKET
  • 1.4 SYNTHETIC BONE GRAFT SUBSTITUTE MARKET
  • 1.5 DEMINERALIZED BONE MATRIX BONE GRAFT SUBSTITUTE MARKET
  • 1.6 HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
  • 1.7 BONE MORPHOGENETIC PROTEIN GROWTH FACTOR MARKET
  • 1.8 AUTOLOGOUS CHONDROCYTE IMPLANTATION MARKET
  • 1.9 COMPETITIVE ANALYSIS

RESEARCH METHODOLOGY

  • 2.1 RESEARCH SCOPE
  • 2.2 IDATA'S 9-STEP METHODOLOGY
    • Step 1: Project Initiation & Team Selection
    • Step 2: Prepare Data Systems and Perform Secondary Research
    • Step 3: Preparation for Interviews & Questionnaire Design
    • Step 4: Performing Primary Research
    • Step 5: Research Analysis: Establishing Baseline Estimates
    • Step 6: Market Forecast and Analysis
    • Step 7: Identify Strategic Opportunities
    • Step 8: Final Review and Market Release
    • Step 9: Customer Feedback and Market Monitoring

EUROPEAN ORTHOPEDIC BIOMATERIALS MARKET

  • 3.1 INTRODUCTION
    • 3.1.1 Products
      • 3.1.1.1 Growth Factors
      • 3.1.1.2 Bone Graft Substitutes
      • 3.1.1.3 Hyaluronic Acid Viscosupplementation
      • 3.1.1.4 Autologous Chondrocyte Implantation
  • 3.2 CURRENCY EXCHANGE RATE
  • 3.3 MARKET OVERVIEW
  • 3.4 TREND ANALYSIS
  • 3.5 DRIVERS AND LIMITERS
    • 3.5.1 Market Drivers
    • 3.5.2 Market Limiters
  • 3.6 COMPETITIVE ANALYSIS
  • 3.7 MERGERS AND ACQUISITIONS

COUNTRY PROFILES

  • 4.1 INTRODUCTION
    • 4.1.1 Population
    • 4.1.2 GDP per Capita
    • 4.1.3 Price Index
  • 4.2 GERMANY
  • 4.3 FRANCE
  • 4.4 UNITED KINGDOM
  • 4.5 ITALY
  • 4.6 SPAIN
  • 4.7 BENELUX
  • 4.8 SCANDINAVIA
  • 4.9 AUSTRIA
  • 4.10 SWITZERLAND
  • 4.11 PORTUGAL

BONE GRAFT SUBSTITUTE MARKET

  • 5.1 INTRODUCTION
    • 5.1.1 Volumes Represented per Procedure
  • 5.2 MARKET OVERVIEW
    • 5.2.1 Bone Graft Substitute Market by Indication
    • 5.2.2 Bone Graft Substitute Market by Segment
  • 5.3 MARKET ANALYSIS AND FORECAST
    • 5.3.1 Total Bone Graft Substitute Market
    • 5.3.2 Total Allograft Market
      • 5.3.2.1 Total Allograft Spine Market
        • 5.3.2.1.1 Allograft Cervical Spine Market
        • 5.3.2.1.2 Allograft Thoracolumbar Spine Market
      • 5.3.2.2 Allograft Trauma and Reconstruction Market
      • 5.3.2.3 Allograft Craniomaxillofacial Market
    • 5.3.3 Total Synthetic Market
      • 5.3.3.1 Total Synthetic Spine Market
        • 5.3.3.1.1 Synthetic Cervical Spine Market
        • 5.3.3.1.2 Synthetic Thoracolumbar Spine Market
      • 5.3.3.2 Synthetic Trauma and Reconstruction Market
      • 5.3.3.3 Synthetic Craniomaxillofacial Market
    • 5.3.4 Total Demineralized Bone Matrix Market
      • 5.3.4.1 Total Demineralized Bone Matrix Spine Market
        • 5.3.4.1.1 Demineralized Bone Matrix Cervical Spine Market
        • 5.3.4.1.2 Demineralized Bone Matrix Thoracolumbar Spine Market
      • 5.3.4.2 Demineralized Bone Matrix Trauma and Reconstruction Market
      • 5.3.4.3 Demineralized Bone Matrix Craniomaxillofacial Market
  • 5.4 DRIVERS AND LIMITERS
    • 5.4.1 Market Drivers
    • 5.4.2 Market Limiters
  • 5.5 COMPETITIVE ANALYSIS

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

  • 6.1 INTRODUCTION
  • 6.2 MARKET OVERVIEW
  • 6.3 MARKET ANALYSIS AND FORECAST
    • 6.3.1 Total Hyaluronic Acid Viscosupplementation Market
    • 6.3.2 Single-Injection Market
    • 6.3.3 Three-Injection Market
    • 6.3.4 Five-Injection Market
  • 6.4 DRIVERS AND LIMITERS
    • 6.4.1 Market Drivers
    • 6.4.2 Market Limiters
  • 6.5 COMPETITIVE ANALYSIS

BONE MORPHOGENETIC PROTEIN GROWTH FACTOR THERAPY MARKET

  • 7.1 INTRODUCTION
  • 7.2 MARKET ANALYSIS AND FORECAST
  • 7.3 MARKET DRIVERS AND LIMITERS
    • 7.3.1 Market Drivers
    • 7.3.2 Market Limiters
  • 7.4 COMPETITIVE ANALYSIS

AUTOLOGOUS CHONDROCYTE IMPLANTATION MARKET

  • 8.1 INTRODUCTION
    • 8.1.1 Future of ACI Treatments
  • 8.2 MARKET ANALYSIS AND FORECAST
  • 8.3 DRIVERS AND LIMITERS
    • 8.3.1 Market Drivers
    • 8.3.2 Market Limiters
  • 8.4 COMPETITIVE ANALYSIS

ABBREVIATIONS

Show More
Pricing
  • Int'l: +1-860-674-8796
  • TollFree(US): +1-866-353-3335
  • Europe: +32-2-535-7543
  • Asia: +65-6223-2436
Back to Top